<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8" />
    <meta http-equiv="x-dns-prefetch-control" content="off" />
    <meta name="viewport" content="width=2048px,user-scalable=no,shrink-to-fit=no"/>
    <meta name="apple-mobile-web-app-capable" content="yes" />
    <meta name="format-detection" content="telephone=no" />
    <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent" />
    <link href="styles/common.css" rel="stylesheet" type="text/css" />
    <link href="styles/style.css" rel="stylesheet" type="text/css" />
        <script type="text/javascript">
            if ('ontouchmove' in document)
                document.addEventListener('touchmove', function (e) { e.preventDefault(); });
    </script>
</head>
<body>
    <div class="body">
       
      <!--  <img  src="styles/images/12.jpg" class="bg"/>-->



        <div id="main_data" class="tab-container active-tab-0">

            <ul class="tab-links">
                <li><a href="javascript:void(0)"><span>Extended-Release Formulation</span></a></li>
                <li><a href="javascript:void(0)"><span>Pharmacokinetic Data</span></a></li>
                <li><a href="javascript:void(0)"><span>Technology Video</span></a></li>

            </ul>
            <div class="tab-pages-container">
                <div class="tab-pages">
                    <div class="page1">

                        <div id="container1">
                            <div class="page1_content">
                                <img src="styles/images/image_main.png" class="main_image" />

                                <img src="styles/images/logo_liq.png" class="inner_logo" />
                            </div>
                            <div class="page1_largecontent">
                                <img src="styles/images/image_main_large.png" />
                                <div id="page1_largecontentClose"></div>
                            </div>
                        </div>
                    </div>
                    <div class="page2">

                        <div class="page2_content">
                            <img src="styles/images/image_chart.png" class="chart_page2" />
                           

                        </div>
                        <!-- <img src="styles/images/logo_liq.png" class="inner_page2_logo" />-->
                        <div class="page2_largecontent">
                        <div id="page2_largecontentClose"></div>
                            <img src="styles/images/image_largepage2.png" class="large_chartpage2" />
                        </div>
                    </div>

                    <div class="page3">
				<div id="emptyDiv">
                </div>
         <div class="tech_video_div">             
        <video id="tech_video" onended="video_ends();">
            <source src="video/MOR_Video Final Composition_640.mp4" type="video/mp4" />
            <p>Your browser does not support the video tag.</p>
        </video>
             
             <a href="javascript:void(0)" class='playpause'>
        <img class="tech_video_poster" src="styles/images/video.png" alt=""/></a>
    <div class="control">
        <a href="javascript:void(0)" class="btnPlay">
            <div>
                &#9658;</div>
        </a>
        <div class="progressBar">
            <div class="timeBar">
                <div class='seek_pointer'>
                </div>
            </div>
        </div>
        <div class="current">
            0:00</div>
        <div class='divider'>
            /</div>
        <div class="duration">
            6:04</div>
    </div>
             </div> 
         <!--<a href="javascript:void(0)" class="tech_video_play"></a>     -->           

                    </div>

                </div>
            </div>
            <ul class='sign_off_layer'>
                <li class="page_number">30.00</li>
            </ul>
            <div id="title_bar">
                <ul>
                   <li class="active" style="left: 28px;top: 1px;line-height: 58px;">
                       
                        <span>Quillivant XR uses</span> <span style="color:#e04a25;">proprietary LiquiXR<sup style="font-weight:bold;">TM</sup> technology,</span> <span>which provides 
                        <br />a combination of approximately</span> <span style="color:#e04a25;">20%</span> <span>immediate-release (IR) and
                        <br /></span> <span style="color:#e04a25;">80%</span> <span>extended-release (ER) methylphenidate</span>
                    </li>
                    <li style="    left: 26px;">
                        
                        <span>The</span> extended-release formulation <span>of Quillivant XR has a </span><span style="color:#e04a25;">direct impact on the <br />
                        pharmacokinetic profile</span>
                        
                    </li>
                     <li style="left: 114px;">
                      
                        <span>Technology Video</span>
                    </li>

                </ul>
            </div>

        </div>


       
        <img class="mainpage-line" src="styles/images/mainpage-line.png" />
        <a href="veeva:gotoSlide(QXR_Quillivant_v4.4_10.00.zip, E19349CE-2314-4ACF-BC28-CBC8F4005B61)" class="logo"></a>
          <div  class="icon"></div>
        <div class="logo_hide"></div>
      
        <a href="veeva:gotoSlide(QXR_Quillivant_v4.4_10.00.zip, E19349CE-2314-4ACF-BC28-CBC8F4005B61)" class="cnc-button"></a>
        <div id="footer">
            <div id="ssi_header_text">
            </div>
            <div id="ssi" class="scrollview">
                <div class="scrollbar">
                    <div class="track">
                        <div class="thumb">
                            <div class="end">
                            </div>
                        </div>
                    </div>
                </div>
                <div class="viewport">
                    <div class="overview">
                        <p class="isi-heading">IMPORTANT SAFETY INFORMATION AND INDICATION</p>
                        <div class="box-border">

                            <p>
                                <span>WARNING: ABUSE AND DEPENDENCE</span><br />
                               CNS stimulants, including Quillivant XR, other methylphenidate-containing products, and amphetamines, have a high potential<br />
                               for abuse and dependence. Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while<br />
                                on therapy.

                            </p>
                        </div>

                        <ul class="isi-list">
                            <li>Quillivant XR is contraindicated:<br />
                                <ul class="isi-sublist">
                                    <li>In patients known to be hypersensitive to methylphenidate or other components of Quillivant XR. Hypersensitivity reactions such as<br />
                                        angioedema and anaphylactic reactions have been reported.
                                    </li>
                                    <li>During treatment with monoamine oxidase inhibitors (MAOIs), and also within 14 days following discontinuation of treatment with an<br />
                                        MAOI because of the risk of hypertensive crisis.
                                    </li>
                                </ul>
                            </li>
                           <li>Sudden death, stroke and myocardial infarction have occurred in adults treated with CNS stimulants at recommended doses. Sudden<br />
                            death has occurred in pediatric patients with structural cardiac abnormalities and other serious cardiac problems, and in adults taking<br />
                            CNS stimulants at recommended doses for ADHD. Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy,<br />
                            serious cardiac arrhythmias, coronary artery disease, or other serious cardiac problems. Further evaluate patients who develop exertional<br />
                            chest pain, unexplained syncope, or arrhythmias during treatment with Quillivant XR.
</li>
                            <li>CNS stimulants cause an increase in blood pressure (mean increase approximately 2‐4 mm Hg) and heart rate (mean increase<br />
                                approximately 3‐6 bpm). Some individuals may have larger increases. Monitor all patients for hypertension and tachycardia.
                            </li>
                            <li>Use of stimulants may cause psychotic or manic symptoms in patients with no prior history, or exacerbation of symptoms in patients with<br />
                                pre‐existing psychiatric illness. Evaluate for bipolar disorder prior to Quillivant XR use.
                            </li>
                            <li>Cases of painful and prolonged penile erections and priapism have been reported with methylphenidate products. Immediate medical
                                <br />
                                attention should be sought if signs or symptoms of prolonged penile erections or priapism are observed.
                            </li>
                            <li>Stimulants used to treat ADHD are associated with peripheral vasculopathy, including Raynaud’s phenomenon. Signs and symptoms are<br />
                            usually intermittent and mild; however, very rare sequelae include digital ulceration and/or soft tissue breakdown. Careful observation for<br />
                            digital changes is necessary during treatment with ADHD stimulants.
                            </li>
                            <li>CNS stimulants have been associated with weight loss and slowing of growth rate in pediatric patients. Growth should be monitored<br />
                                during treatment with stimulants, including Quillivant XR. Patients who are not growing or gaining weight as expected may need to have
                                <br />
                                their treatment interrupted.
                            </li>
                            <li>Based on accumulated data from other methylphenidate products, the most common (≥5% and twice the rate of placebo) adverse<br />reactions are 
                            </li>
     <table class="isi_footertable">
                            <table class="isi_footertable">
                            <tr>
                            <td>appetite decreased</td><td>dyspepsia</td><td>dizziness</td>
                           </tr>
                           <tr>
                           <td>insomnia</td><td>abdominal pain</td><td>irritability</td>
                           </tr>
                           <tr>
                           <td>nausea</td><td>weight decreased</td><td>affect lability</td>
                           </tr>
                           <tr>
                           <td>vomiting</td><td>anxiety</td><td>tachycardia</td>
                           </tr>
                           <tr>
                           <td></td><td></td><td>blood pressure increased</td>
                           </tr>
                           </table>
                  
                         <p style="margin-left:15px;">
                            There is limited experience with Quillivant XR in controlled trials.  
                        </p>
                        	<ul class="isi-sublist">
                                    <li>The most common (≥2% in the Quillivant XR group and greater than placebo) adverse reactions reported in the Phase 3 controlled study<br />
                                    conducted in 45 ADHD patients (ages 6-12 years) in Quillivant XR compared to placebo were affect lability (9% Quillivant XR,<br />
                                    2% placebo), excoriation (4%, 0%), initial insomnia (2%, 0%), tic (2%, 0%), decreased appetite (2%, 0%), vomiting (2%, 0%), motion<br />
                                    sickness (2%, 0%), eye pain (2%, 0%), and rash (2%, 0%).   
                                    </li>
                                </ul>
                            
                            <li>CNS stimulant medications, such as Quillivant XR, can cause vasoconstriction and thereby decrease placental perfusion. No fetal and/or<br />
                            neonatal adverse reactions have been reported with the use of therapeutic doses of methylphenidate during pregnancy; however,<br />
                            premature delivery and low birth weight infants have been reported in amphetamine-dependent mothers. 
                            </li>
                            <li>The developmental and health benefits of breastfeeding should be considered along with mother’s clinical need for Quillivant XR and any<br />
                            potential adverse effects on the breastfed infant from Quillivant XR or from the underlying maternal condition. Monitor breastfeeding<br />
                            infants for adverse reactions, such as agitation, insomnia, anorexia, and reduced weight gain.
                            </li>
                        </ul>

                        <p class="isi-heading margins">INDICATION</p>
                        <p class="indication_content">
                            Quillivant XR is a central nervous system (CNS) stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD). 
                        </p>

                    </div>
                </div>
            </div>
            <ul id="toolbar">
                <li class="sd disabled"><a href="javascript:void(0)"><span>STUDY<br />
                    DESCRIPTION</span></a></li>
                <li class="reference disabled"><a href="javascript:void(0)"><span>REFERENCES</span></a></li>
                <li class="isi"><a href="javascript:void(0)"><span>ISI AND<br />
                    INDICATION</span></a></li>
                <li class="pi"><a href="javascript:void(0)" target="_blank" style="background-color:#7d98a9; color:#FFFFFF;"><span>PI/MED GUIDE</span></a></li>
            </ul>
        </div>
    </div>
</body>
<script src="scripts/jquery.js" type="text/javascript"></script>
<script src="scripts/jquery.iscroll.js" type="text/javascript"></script>
<script src="scripts/common.js" type="text/javascript"></script>
<script src="scripts/app.js" type="text/javascript"></script>
<script src="scripts/popup.js"></script>
<script src="scripts/tabs.js" type="text/javascript"></script>

<script src="scripts/veeva.js" type="text/javascript"></script>




<script src="scripts/jquery.multiswipe.js" type="text/javascript"></script>


<script type="text/javascript" src="scripts/tracking.js"></script>
<script type="text/javascript" src="scripts/clm-library-1.4.js"></script>
<script src="scripts/assettracking.js" type="text/javascript"></script>
<script src="scripts/script.js" type="text/javascript"></script>
<script type="text/javascript">
    app.showSignOff = true
    app.slides.currentSlideId = "30.00";
    app.slides.summarySlideId = "QXR_Quillivant_v4.4_10.00";
    var slideMetadata = { id: 'E217A7AD-E3E9-4117-BB25-31AFCB879E3C', internalName: 'Extended-Release Formulation', version: '4.0.0', externalName: 'Extended-Release Formulation', isChild: false };
	
	var sd_tab = {
    click: function () {
		$('#ref_popup_tab,#isi_popup').removeClass('visible');
        popups.sd_popup_tab.show();
		
    }
};
var reference_tab = {
    click: function () {
		//$('.close').trigger('click');
		$('#sd_popup_tab,#isi_popup').removeClass('visible');
        popups.ref_popup_tab.show();
    }
};
var checktab = false;
    app.slides.load = function () {
        app.slides.currentSlideId = "30.00";
        //app.slides.currentAssetId = 'DA692E9B-A9E4-461B-880D-F2168DF42449';
        veeva.trackSlide(slideMetadata);
        //app.slides.currentSlide = slideMetadata;
		//app.slides.currentSlideId = '30.00';
    app.slides.summarySlideId = 'QXR_Quillivant_v4.4_10.00';
   // app.slides.currentAssetId = 'E217A7AD-E3E9-4117-BB25-31AFCB879E3C';

    //app.tracking.trackSlideVisit();

    $('ul#toolbar li .sd').addClass('disabled');


/*$('.pi').on("touchend click",function () {
		location = "pdf/PI.pdf";
		 video[0].pause();
         video[0].currentTime = 0;
        $('.control').show();
			 $('.btnPlay > div').removeClass('show_pause');
			 $('.btnPlay > div').html(' &#9658;');
			 clearTimeout(time1);
			 time1 = setTimeout(function () { $('.control').show(); }, 3000);

    });*/



    $(".page1_content").click(function () {
        $(".page1_largecontent").show();
        $(".page1_content").css('opacity', '0.1');
    
         $scroller.disable();
        $("#title_bar").css('z-index', '8');
    });

    $("#page1_largecontentClose").click(function () {
        $(".page1_content").show();
        $(".page1_content").css('opacity', '1');
        $(".page1_largecontent").hide();
        $("#title_bar").css('z-index', '11');
		 $scroller.enable();
    });

    $(".page2_content").click(function () {
        $(".page2_largecontent").show();
        $(".page2_content").css('opacity', '0.1');
        //$(".inner_page2_logo").css('opacity', '1');
		$scroller.disable();
    });

    $("#page2_largecontentClose").click(function () {
        $(".page2_content").show();
        $(".page2_content").css('opacity', '1');
        $(".page2_largecontent").hide();
		$scroller.enable();
    });





    $('#main_data').tabs({
        titles: $('#title_bar'),
        tabchange: function (index) {
            app.slides.currentSlide = slideMetadatas[index];
            $("#title_bar .upper").removeClass('active');
			
            if (index == 0) {
                //this is tab 4.2
				$("#page2_largecontentClose").trigger("click");
                app.slides.currentSlideId = '30.00';
				$('.page_number').html('30.00');
                $(".page1_largecontent").hide();
                $(".page1_content").css('opacity', '1');
                video_ends();
                //$('video#tech_video')[0].pause();
                //$('video#tech_video')[0].currentTime = 0;
                
                $('.btnPlay div').removeClass('show_pause');
                $('.btnPlay div').html('&#9658;');
				//app.slides.currentSlide.isChild = "if(index==0)";
				//veeva.trackSlide(slideMetadatas[index]);
				//app.slides.currentSlide = slideMetadatas[0];
				
				if(checktab == true)
				{
					veeva.trackSlide({id: 'E217A7AD-E3E9-4117-BB25-31AFCB879E3C', internalName: 'Extended-Release Formulation', version: '4.0.0', externalName: 'Extended-Release Formulation', isChild: false });
				}
				else
				{
					app.slides.currentSlide.isChild = "if(index!=0)";
					//veeva.trackSlide({id: 'E217A7AD-E3E9-4117-BB25-31AFCB879E3C', internalName: 'Extended-Release Formulation', version: '4.0.0', externalName: 'Extended-Release Formulation', isChild: false });
				}
				//alert(JSON.stringify(slideMetadatas[index]));

               // app.slides.currentAssetId = 'E217A7AD-E3E9-4117-BB25-31AFCB879E3C'; 
            }
            else if (index == 1) {
				checktab = true;
				$("#page1_largecontentClose").trigger("click");
				//trackAction('tracking_element_id1')
                app.slides.currentSlideId = '30.10';
				$('.page_number').html('30.10');
                $(".page2_largecontent").hide();
                $(".page2_content").css('opacity', '1');
                video_ends();
                //$('video#tech_video')[0].pause();
                //$('video#tech_video')[0].currentTime = 0;
                $(".control").show();
                $('.page3 > .tech_video_div  img.tech_video_poster').css('display', 'block');
                $('.btnPlay div').removeClass('show_pause');
                $('.btnPlay div').html('&#9658;');

				veeva.trackSlide({id: '11B43A93-E91A-44AF-81E7-60ED986DC56C', internalName: 'Pharmacokinetic Data liquid', version: '4.0.0', externalName: 'Pharmacokinetic Data liquid', isChild: true });
               // app.slides.currentAssetId = '11B43A93-E91A-44AF-81E7-60ED986DC56C';
               // app.slides.currentSlide.isChild = "if(index!=0)";
              
            }
            else if (index == 2) {
                //this is tab 4.1
				$("#page1_largecontentClose, #page2_largecontentClose").trigger("click");
				//trackAction('tracking_element_id2')
                app.slides.currentSlideId = '30.20';
				$('.page_number').html('30.20');
                if (img.css("display") == 'none') {

                    img.css("display", "block");
                }
				veeva.trackSlide({id: '43896308-8DE8-44C0-A24C-A0CC131020C6', internalName: 'Technology Video', version: '4.0.0', externalName: 'Technology Video', isChild: true });
               // app.slides.currentAssetId = '43896308-8DE8-44C0-A24C-A0CC131020C6';
                
                if (flag == 0) {
                    videoscript();
                    flag = 1;
                }
                
                $('.control').show();
               // app.slides.currentSlide.isChild = "if(index!=0)";
            }

            //veeva.trackSlide({ id: app.slides.currentAssetId, isChild: index != 0 });
            app.tracking.trackSlideVisit();
        }
    });
	
    }
	
app.footer.buttons.sd = sd_tab;
    app.footer.buttons.reference = reference_tab
    popups.add('sd_popup_tab', {
        url: 'study.html', class: 'small', scrollable: false, title: 'SKAMP Study Description', group: 'footer',
        onopen: function () {
            $(".logo_hide").css('display', 'block');
            $(".logo").css('width', '580px');
            $(".logo").css('right', '5px');
            $(".mainpage-line").css('display', 'block');
            $("#vLine").css('display', 'none');
            $("#child-img").css('display', 'none');
            $(".liquidLogo").css('display', 'none');
           
        },
        onclose: function () {
		    $(".liquidLogo,.bottom_bar,.bottom_text,#bottom_image,#arrow-circle,#q-page-content-des,#q-page-header").css('display', 'block');
            $("#vLine").css('display', 'block');
            $('.sd').removeClass('active');
            $(".logo_hide").css('display', 'none');
            $(".logo").css('width', '660px');
            $(".logo").css('right', '1158px');
            $(".mainpage-line").css('display', 'none');
            $("#child-img").css('display', 'block');
            $(".liquidLogo").css('display', 'block');
        }
    });
	
	popups.add('ref_popup_tab', {
        url: 'references.html', class: 'small', scrollable: false, title: 'References', group: 'footer',
        onopen: function () {//alert(1);
		    
            $(".logo_hide").css('display', 'block');
            $(".logo").css('width', '580px');
            $(".logo").css('right', '0px');
            $(".mainpage-line").css('display', 'block');
            $("#vLine").css('display', 'none');
            $("#child-img").css('display', 'none');
            $(".liquidLogo").css('display', 'none');
        },
        onclose: function () {
		    $(".liquidLogo,.bottom_bar,.bottom_text,#bottom_image,#arrow-circle,#q-page-content-des,#q-page-header").css('display', 'block');
            $('.reference').removeClass('active');
            $(".logo_hide").css('display', 'none');
            $(".logo").css('width', '660px');
            $(".logo").css('right', '1158px');
            $(".mainpage-line").css('display', 'none');
            $("#vLine").css('display', 'block');
            $("#child-img").css('display', 'block');
            $(".liquidLogo").css('display', 'block');
        }
    });
  
   
   veeva = {
    gotoSlide: function (slide) {
		pageUnload();
        document.location = "veeva:gotoSlide(" + slide + ".zip)";
    },
    saveObject: function (objectName, value, callback) {
        this.callbackIndex = this.callbackIndex || 0;
        this.callbackIndex++;
        var callbackName = "objectSavedCallback_" + this.callbackIndex;
        window[callbackName] = callback;
        if (!(typeof value == 'string' || value instanceof String))
            value = JSON.stringify(value);
        document.location = "veeva:saveObject(" + objectName + "),value(" + value + "),callback(" + callbackName + ")";
    },
    saveClickstreamObject: function (value, callback) {
        this.saveObject("Call_Clickstream_vod__c", value, callback);
    },
    trackSlide: function (o, callback) {
        app.tracking.trackSlideVisit(o);
        
    },
    saveFeedback: function (assetId) {
        var clickStream = '{"Survey_Type_vod__c":"Tab", "Question_vod__c":"' + assetId + '", "Answer_vod__c":"Visited"}';
       

    }
	
    }
	
    
</script>
<script>


$(document).ready(function(){

   $(".icon").on('click', function(){
             

      if($(".page1").hasClass("active")){
            localStorage.setItem("pageNo", "1");
      }else if($(".page2").hasClass("active")){
            localStorage.setItem("pageNo", "2");
      }else if($(".page3").hasClass("active")){
            localStorage.setItem("pageNo", "3");
      }


       window.location.href = "veeva:gotoSlide(QER_Quillichew_v1.4_30.00.zip, QER Quillichew 1.4 Test)";
   });
    

});

</script>
</html>
